Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cross Country Healthcare (CCRN) Cash & Current Investments (2016 - 2025)

Cross Country Healthcare (CCRN) has disclosed Cash & Current Investments for 16 consecutive years, with $99.1 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Cash & Current Investments rose 54.84% year-over-year to $99.1 million, compared with a TTM value of $99.1 million through Sep 2025, up 54.84%, and an annual FY2024 reading of $81.6 million, up 377.55% over the prior year.
  • Cash & Current Investments was $99.1 million for Q3 2025 at Cross Country Healthcare, up from $81.2 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $99.1 million in Q3 2025 and bottomed at $279000.0 in Q2 2022.
  • Average Cash & Current Investments over 5 years is $30.7 million, with a median of $14.3 million recorded in 2023.
  • The sharpest move saw Cash & Current Investments tumbled 98.46% in 2022, then soared 10241.9% in 2024.
  • Year by year, Cash & Current Investments stood at $1.0 million in 2021, then skyrocketed by 247.88% to $3.6 million in 2022, then skyrocketed by 374.31% to $17.1 million in 2023, then surged by 377.55% to $81.6 million in 2024, then rose by 21.44% to $99.1 million in 2025.
  • Business Quant data shows Cash & Current Investments for CCRN at $99.1 million in Q3 2025, $81.2 million in Q2 2025, and $80.7 million in Q1 2025.